Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bruker Corporation stock logo
BRKR
Bruker
$36.59
+1.0%
$33.10
$28.53
$65.25
$5.50B1.23.94 million shs2.26 million shs
Illumina, Inc. stock logo
ILMN
Illumina
$90.30
-5.0%
$98.13
$68.70
$156.66
$14.61B1.41.63 million shs2.56 million shs
Revvity Inc. stock logo
RVTY
Revvity
$91.52
+0.6%
$88.18
$81.36
$129.50
$10.56B0.981.26 million shs1.20 million shs
Bio-Techne Corp stock logo
TECH
Bio-Techne
$59.11
-0.9%
$54.65
$46.01
$80.80
$9.23B1.482.83 million shs1.69 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bruker Corporation stock logo
BRKR
Bruker
+0.80%+5.67%+18.15%-12.08%-42.40%
Illumina, Inc. stock logo
ILMN
Illumina
-4.24%-5.88%-4.33%-6.15%-38.95%
Revvity Inc. stock logo
RVTY
Revvity
-0.14%-0.22%+9.86%-4.14%-25.96%
Bio-Techne Corp stock logo
TECH
Bio-Techne
-0.64%+0.14%+15.63%+14.44%-19.71%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bruker Corporation stock logo
BRKR
Bruker
$36.59
+1.0%
$33.10
$28.53
$65.25
$5.50B1.23.94 million shs2.26 million shs
Illumina, Inc. stock logo
ILMN
Illumina
$90.30
-5.0%
$98.13
$68.70
$156.66
$14.61B1.41.63 million shs2.56 million shs
Revvity Inc. stock logo
RVTY
Revvity
$91.52
+0.6%
$88.18
$81.36
$129.50
$10.56B0.981.26 million shs1.20 million shs
Bio-Techne Corp stock logo
TECH
Bio-Techne
$59.11
-0.9%
$54.65
$46.01
$80.80
$9.23B1.482.83 million shs1.69 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bruker Corporation stock logo
BRKR
Bruker
+0.80%+5.67%+18.15%-12.08%-42.40%
Illumina, Inc. stock logo
ILMN
Illumina
-4.24%-5.88%-4.33%-6.15%-38.95%
Revvity Inc. stock logo
RVTY
Revvity
-0.14%-0.22%+9.86%-4.14%-25.96%
Bio-Techne Corp stock logo
TECH
Bio-Techne
-0.64%+0.14%+15.63%+14.44%-19.71%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bruker Corporation stock logo
BRKR
Bruker
2.36
Hold$51.0039.38% Upside
Illumina, Inc. stock logo
ILMN
Illumina
2.15
Hold$123.5636.83% Upside
Revvity Inc. stock logo
RVTY
Revvity
2.60
Moderate Buy$117.9328.86% Upside
Bio-Techne Corp stock logo
TECH
Bio-Techne
2.63
Moderate Buy$70.5819.41% Upside

Current Analyst Ratings Breakdown

Latest RVTY, BRKR, ILMN, and TECH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/14/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
10/14/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$65.00 ➝ $70.00
10/8/2025
Bruker Corporation stock logo
BRKR
Bruker
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
10/8/2025
Illumina, Inc. stock logo
ILMN
Illumina
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
10/8/2025
Revvity Inc. stock logo
RVTY
Revvity
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C-)Sell (D+)
10/8/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
10/7/2025
Illumina, Inc. stock logo
ILMN
Illumina
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$135.00 ➝ $132.00
10/7/2025
Revvity Inc. stock logo
RVTY
Revvity
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$108.00 ➝ $106.00
10/7/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$60.00 ➝ $72.00
10/6/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong SellHold
10/2/2025
Revvity Inc. stock logo
RVTY
Revvity
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$110.00 ➝ $100.00
(Data available from 10/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bruker Corporation stock logo
BRKR
Bruker
$3.37B1.65$3.63 per share10.09$11.85 per share3.09
Illumina, Inc. stock logo
ILMN
Illumina
$4.37B3.17$4.46 per share20.26$14.96 per share6.04
Revvity Inc. stock logo
RVTY
Revvity
$2.80B3.80$8.57 per share10.68$63.00 per share1.45
Bio-Techne Corp stock logo
TECH
Bio-Techne
$1.22B7.55$2.42 per share24.40$12.24 per share4.83
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bruker Corporation stock logo
BRKR
Bruker
$113.10M$0.5270.2311.625.052.31%17.89%5.38%11/4/2025 (Estimated)
Illumina, Inc. stock logo
ILMN
Illumina
-$1.22B$7.9011.5217.502.2929.36%28.93%10.74%11/3/2025 (Estimated)
Revvity Inc. stock logo
RVTY
Revvity
$270.39M$2.3638.5616.463.0310.19%7.66%4.73%10/27/2025 (Estimated)
Bio-Techne Corp stock logo
TECH
Bio-Techne
$73.40M$0.46128.8530.013.806.02%13.43%10.32%10/29/2025 (Estimated)

Latest RVTY, BRKR, ILMN, and TECH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2025Q3 2025
Bruker Corporation stock logo
BRKR
Bruker
$0.33N/AN/AN/A$847.40 millionN/A
11/3/2025Q3 2025
Illumina, Inc. stock logo
ILMN
Illumina
$1.16N/AN/AN/A$1.07 billionN/A
10/29/2025Q1 2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.42N/AN/AN/AN/AN/A
10/27/2025Q3 2025
Revvity Inc. stock logo
RVTY
Revvity
$1.14N/AN/AN/A$699.75 millionN/A
8/6/2025Q4 2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.50$0.53+$0.03-$0.11$315.14 million$316.96 million
8/4/2025Q2 2025
Bruker Corporation stock logo
BRKR
Bruker
$0.33$0.32-$0.01$0.05$811.17 million$797.40 million
7/31/2025Q2 2025
Illumina, Inc. stock logo
ILMN
Illumina
$1.02$1.19+$0.17$1.50$1.12 billion$1.06 billion
7/28/2025Q2 2025
Revvity Inc. stock logo
RVTY
Revvity
$1.14$1.18+$0.04$0.46$711.26 million$720.28 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bruker Corporation stock logo
BRKR
Bruker
$0.200.55%N/A38.46%N/A
Illumina, Inc. stock logo
ILMN
Illumina
N/AN/AN/AN/AN/A
Revvity Inc. stock logo
RVTY
Revvity
$0.280.31%N/A11.86%N/A
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.320.54%N/A69.57%N/A

Latest RVTY, BRKR, ILMN, and TECH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/24/2025
Revvity Inc. stock logo
RVTY
Revvity
quarterly$0.070.27%10/17/202510/17/202511/7/2025
8/7/2025
Bruker Corporation stock logo
BRKR
Bruker
quarterly$0.050.6%9/23/20259/23/202510/3/2025
8/6/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
quarterly$0.080.59%8/18/20258/18/20258/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bruker Corporation stock logo
BRKR
Bruker
1.31
1.61
0.70
Illumina, Inc. stock logo
ILMN
Illumina
0.66
1.81
1.41
Revvity Inc. stock logo
RVTY
Revvity
0.43
3.33
2.75
Bio-Techne Corp stock logo
TECH
Bio-Techne
0.18
3.46
2.38

Institutional Ownership

CompanyInstitutional Ownership
Bruker Corporation stock logo
BRKR
Bruker
79.52%
Illumina, Inc. stock logo
ILMN
Illumina
89.42%
Revvity Inc. stock logo
RVTY
Revvity
86.65%
Bio-Techne Corp stock logo
TECH
Bio-Techne
98.95%

Insider Ownership

CompanyInsider Ownership
Bruker Corporation stock logo
BRKR
Bruker
27.30%
Illumina, Inc. stock logo
ILMN
Illumina
0.17%
Revvity Inc. stock logo
RVTY
Revvity
0.68%
Bio-Techne Corp stock logo
TECH
Bio-Techne
1.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bruker Corporation stock logo
BRKR
Bruker
11,396151.72 million110.30 millionOptionable
Illumina, Inc. stock logo
ILMN
Illumina
9,030153.70 million153.44 millionOptionable
Revvity Inc. stock logo
RVTY
Revvity
11,000116.07 million115.28 millionOptionable
Bio-Techne Corp stock logo
TECH
Bio-Techne
3,100155.69 million153.67 millionOptionable

Recent News About These Companies

GMAB or TECH: Which Is the Better Value Stock Right Now?
Bio-Techne (NASDAQ:TECH) Price Target Raised to $70.00
Earnings Preview: What to Expect From Bio-Techne's Report
Bio-Techne (TECH) Receives a Buy from Evercore ISI
Citi Sticks to Their Buy Rating for Bio-Techne (TECH)
5 Analysts Assess Bio-Techne: What You Need To Know

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bruker stock logo

Bruker NASDAQ:BRKR

$36.59 +0.36 (+0.99%)
As of 09:31 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Illumina stock logo

Illumina NASDAQ:ILMN

$90.30 -4.73 (-4.98%)
As of 09:31 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Revvity stock logo

Revvity NYSE:RVTY

$91.52 +0.54 (+0.59%)
As of 09:31 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Bio-Techne stock logo

Bio-Techne NASDAQ:TECH

$59.11 -0.54 (-0.90%)
As of 09:31 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.